Cargando…

Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells

Current therapies for prostate cancer include antiandrogens, inhibitory ligands of the androgen receptor, which repress androgen-stimulated growth. These include the selective androgen receptor modulators cyproterone acetate and hydroxyflutamide and the complete antagonist bicalutamide. Their activi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brooke, Greg N., Gamble, Simon C., Hough, Michael A., Begum, Shajna, Dart, D. Alwyn, Odontiadis, Michael, Powell, Sue M., Fioretti, Flavia M., Bryan, Rosie A., Waxman, Jonathan, Wait, Robin, Bevan, Charlotte L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Biochemistry and Molecular Biology 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424393/ https://www.ncbi.nlm.nih.gov/pubmed/25693800 http://dx.doi.org/10.1074/mcp.M113.036764

Ejemplares similares

Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
por: Dart, D Alwyn, et al.
Publicado: (2009)

Visualising Androgen Receptor Activity in Male and Female Mice
por: Dart, D. Alwyn, et al.
Publicado: (2013)

Engineered repressors are potent inhibitors of androgen receptor activity
por: Brooke, Greg N., et al.
Publicado: (2014)

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens
por: Dart, D. A., et al.
Publicado: (2011)

Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
por: Giotis, Efstathios S., et al.
Publicado: (2022)

Proteome analysis of serovars Typhimurium and Pullorum of Salmonella enterica subspecies I
por: Encheva, Vesela, et al.
Publicado: (2005)

Antiandrogens Target TMPRSS2 and Reduce SARS-CoV-2 Virus Entry in Lung Cells
por: Leach, Damien A, et al.
Publicado: (2021)

Androgens and environmental antiandrogens affect reproductive development and play behavior in the Sprague-Dawley rat.
por: Hotchkiss, A K, et al.
Publicado: (2002)

Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals.
por: Körner, Wolfgang, et al.
Publicado: (2004)

Efficacy of Alternative Antiandrogen Therapy for Prostate Cancer That Relapsed after Initial Maximum Androgen Blockade
por: Choi, Joon Il, et al.
Publicado: (2011)

GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
por: Lee, Eugine, et al.
Publicado: (2019)

A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response
por: Siciliano, Tiziana, et al.
Publicado: (2021)

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
por: Wu, Meng, et al.
Publicado: (2023)

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis
por: Sun, Rui, et al.
Publicado: (2023)

Bioluminescence Microscopy as a Method to Measure Single Cell Androgen Receptor Activity Heterogeneous Responses to Antiandrogens
por: Jain, Pallavi, et al.
Publicado: (2016)

Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide
por: Hoefer, Julia, et al.
Publicado: (2016)

Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen
por: Takeda, Keisuke, et al.
Publicado: (2016)

Acetyl-CoA Counteracts the Inhibitory Effect of Antiandrogens on Androgen Receptor Signaling in Prostate Cancer Cells
por: Makhov, Peter, et al.
Publicado: (2022)

Antiandrogenic Effects of a Polyphenol in Carex kobomugi through Inhibition of Androgen Synthetic Pathway and Downregulation of Androgen Receptor in Prostate Cancer Cell Lines
por: Kudo, Yudai, et al.
Publicado: (2022)

Advances in genetics: widening our understanding of prostate cancer
por: Pine, Angela C., et al.
Publicado: (2016)

Competitive Androgen Receptor Antagonism as a Factor Determining the Predictability of Cumulative Antiandrogenic Effects of Widely Used Pesticides
por: Orton, Frances, et al.
Publicado: (2012)

Corrigendum: Bioluminescence Microscopy as a Method to Measure Single Cell Androgen Receptor Activity Heterogeneous Responses to Antiandrogens
por: Jain, Pallavi, et al.
Publicado: (2016)

Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens
por: Ito, Yusuke, et al.
Publicado: (2018)

The OECD Program to Validate the Rat Hershberger Bioassay to Screen Compounds for in Vivo Androgen and Antiandrogen Responses: Phase 2 Dose–Response Studies
por: Owens, William, et al.
Publicado: (2007)

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
por: Leach, D. A., et al.
Publicado: (2021)

“True” Antiandrogens—Selective Non-Ligand-Binding Pocket Disruptors of Androgen Receptor–Coactivator Interactions: Novel Tools for Prostate Cancer
por: Caboni, Laura, et al.
Publicado: (2012)

Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells
por: Ottaviani, Silvia, et al.
Publicado: (2013)

Advantage of soybean isoflavone as antiandrogen on acne vulgaris
por: Riyanto, Puguh, et al.
Publicado: (2015)

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment
por: Besançon, Marjorie, et al.
Publicado: (2022)

Themis2/ICB1 Is a Signaling Scaffold That Selectively Regulates Macrophage Toll-Like Receptor Signaling and Cytokine Production
por: Peirce, Matthew J., et al.
Publicado: (2010)

Overcoming mutation-based resistance to antiandrogens with rational drug design
por: Balbas, Minna D, et al.
Publicado: (2013)

Designer antiandrogens join the race against drug resistance
por: Josan, Jatinder S, et al.
Publicado: (2013)

Reversing resistance to antiandrogens with a histone deacetylase inhibitor
por: Ferrari, Anna C.
Publicado: (2018)

Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
por: Maitland, Norman J.
Publicado: (2021)

Rational Second-Generation Antiandrogen Use in Prostate Cancer
por: Orme, Jacob J, et al.
Publicado: (2022)

The Role of Androgen Receptor Mutations in Prostate Cancer Progression
por: Brooke, G.N, et al.
Publicado: (2009)

Antiandrogenic activity and metabolism of the organophosphorus pesticide fenthion and related compounds.
por: Kitamura, Shigeyuki, et al.
Publicado: (2003)

Persistent genital arousal disorder: Successful treatment with leuprolide (antiandrogen)
por: Deka, Kamala, et al.
Publicado: (2015)

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
por: Verma, Shiv, et al.
Publicado: (2020)

Physicochemical Profile of Antiandrogen Drug Bicalutamide: Solubility, Distribution, Permeability
por: Volkova, Tatyana V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cmbm0bs32e2nkgt7h2qu8tgsbp